787 Seventh Avenue 49th Floor,
New York, New York 10019
United States
(212) 867-8935
www.edgemontcapital.com
contact@edgemont.com
Edgemont Capital Partners is an investment banking and financial advisory firm focused on serving clients in the healthcare sector. Edgemont assists with mergers & acquisitions, pharmaceutical products licensing services, capital raising, recapitalizations, and fairness/valuation opinions. Edgemont Capital Partners was established in 2001 and is based in New York, New York.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T |
|---|---|---|---|---|---|---|---|
| Buyside (1.8/yr) | 3 | 4 | 3 | - | 2 | - | 12 |
| Sellside (2.4/yr) | 23 | 5 | 5 | 1 | 1 | - | 35 |
| 47 | |||||||
| Target Company | Date | Value | Type |
|---|---|---|---|
| Sign-up to View | 2024-12-10 | - | Digital Media |
| Sign-up to View | 2024-06-06 | - | Consumer Services |
| Sign-up to View | 2024-05-21 | - | Life Science |
| Sign-up to View | 2023-09-07 | - | Life Science |
| Sign-up to View | 2022-12-31 | - | Consumer Products |
| Sign-up to View | 2022-12-31 | - | Safety/Security |
| Sign-up to View | 2022-09-15 | - | Healthcare Services |
| Sign-up to View | 2022-08-23 | - | Life Science |
| Sign-up to View | 2022-08-03 | - | Business Services |
| Sign-up to View | 2022-07-26 | - | Healthcare Services |
| View All >> | |||
| Sector | # | Value | |
|---|---|---|---|
| Healthcare Services | Sign-up to View | ||
| Life Science | Sign-up to View | ||
| Marketing | Sign-up to View | ||
| Business Services | Sign-up to View | ||
| Staffing | Sign-up to View | ||
| Medical Products | Sign-up to View | ||
| Consumer Products | Sign-up to View | ||
| Safety/Security | Sign-up to View | ||
| Consumer Services | Sign-up to View | ||
| Digital Media | Sign-up to View | ||
| Total | Sign-up to View | ||
| State/Country | # | Value | |
|---|---|---|---|
| United States | Sign-up to View | ||
| Massachusetts | Sign-up to View | ||
| North Carolina | Sign-up to View | ||
| Canada | Sign-up to View | ||
| Switzerland | Sign-up to View | ||
| Domestic | Sign-up to View | ||
| Cross-border | Sign-up to View | ||
| Total | Sign-up to View | ||
| Type | # | Value | |
|---|---|---|---|
| Add-on Acquisition | Sign-up to View | ||
| Secondary Buyout | Sign-up to View | ||
| Buyout (LBO, MBO, MBI) | Sign-up to View | ||
| Divestiture | Sign-up to View | ||
| Recapitalization | Sign-up to View | ||
| Growth Capital | Sign-up to View | ||
| Total | Sign-up to View | ||
| PE Firms (9) | Deals |
|---|---|
|
Sign-up to View |
2 |
|
Sign-up to View |
1 |
|
Sign-up to View |
1 |
| Corporate (36) | Deals |
|---|---|
|
Sign-up to View |
3 |
|
Sign-up to View |
1 |
|
Sign-up to View |
1 |
| Value | # | TOTAL |
|---|---|---|
| $100M to $1B | Sign-up to View | |
| < $100M | Sign-up to View | |
| TOTAL | Sign-up to View | |
| Largest |
Abveris, Inc. $190M (2021-11-22) |
|
